JP2003246735A5 - - Google Patents

Download PDF

Info

Publication number
JP2003246735A5
JP2003246735A5 JP2002366375A JP2002366375A JP2003246735A5 JP 2003246735 A5 JP2003246735 A5 JP 2003246735A5 JP 2002366375 A JP2002366375 A JP 2002366375A JP 2002366375 A JP2002366375 A JP 2002366375A JP 2003246735 A5 JP2003246735 A5 JP 2003246735A5
Authority
JP
Japan
Prior art keywords
active ingredient
tetrahydrothieno
cyclopropylcarbonyl
fluorobenzyl
acetoxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002366375A
Other languages
English (en)
Japanese (ja)
Other versions
JP4029974B2 (ja
JP2003246735A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2002366375A priority Critical patent/JP4029974B2/ja
Priority claimed from JP2002366375A external-priority patent/JP4029974B2/ja
Publication of JP2003246735A publication Critical patent/JP2003246735A/ja
Publication of JP2003246735A5 publication Critical patent/JP2003246735A5/ja
Application granted granted Critical
Publication of JP4029974B2 publication Critical patent/JP4029974B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002366375A 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬 Expired - Lifetime JP4029974B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2002366375A JP4029974B2 (ja) 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2001388757 2001-12-21
JP2001-388757 2001-12-21
JP2002366375A JP4029974B2 (ja) 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬

Publications (3)

Publication Number Publication Date
JP2003246735A JP2003246735A (ja) 2003-09-02
JP2003246735A5 true JP2003246735A5 (https=) 2005-06-09
JP4029974B2 JP4029974B2 (ja) 2008-01-09

Family

ID=28676969

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2002366375A Expired - Lifetime JP4029974B2 (ja) 2001-12-21 2002-12-18 ヒドロピリジン誘導体酸付加塩を含有する医薬

Country Status (1)

Country Link
JP (1) JP4029974B2 (https=)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9034860B2 (en) 2006-12-07 2015-05-19 Daiichi Sankyo Company, Limited Pharmaceutical composition containing low-substituted hydroxypropyl cellulose
JPWO2008069262A1 (ja) * 2006-12-07 2010-03-25 第一三共株式会社 安定性が改善されたフィルムコーティング製剤
CA2672134C (en) * 2006-12-07 2015-02-10 Daiichi Sankyo Company, Limited Solid medicinal preparation containing mannitol or lactose
CA2672157C (en) * 2006-12-07 2016-07-26 Daiichi Sankyo Company, Limited Method for producing solid preparation
CN101600431B (zh) * 2006-12-07 2011-09-07 第一三共株式会社 具有改进贮存稳定性的药物组合物
NZ579993A (en) * 2007-03-02 2012-06-29 Daiichi Sankyo Co Ltd Process for production of prasugrel hydrochloride having high purity
US20100261908A1 (en) * 2007-11-09 2010-10-14 Dr. Reddy's Laboratories Ltd. Processes for the preparation of prasugrel , and its salts and polymorphs
TW201211036A (en) * 2010-06-17 2012-03-16 Kyowa Hakko Kirin Co Ltd Useful salts of indazole derivative
TR201007926A1 (tr) * 2010-07-19 2012-02-21 Sanovel İlaç San.Ve Ti̇c.A.Ş. Prasugrel tablet formülasyonları.
TR201006802A1 (tr) * 2010-08-17 2012-03-21 Sanovel İlaç San. Ve Ti̇c. A.Ş. Prasugrelin oral yolla dağılan formülasyonları.
EP2409685A3 (en) * 2010-07-19 2012-02-01 Sanovel Ilac Sanayi ve Ticaret A.S. Orally-disintegrating formulations of prasugrel
CN102775422B (zh) * 2012-03-13 2014-12-31 山东新华制药股份有限公司 普拉格雷中间体的一种晶型
CN104592250B (zh) * 2015-01-15 2016-05-11 新发药业有限公司 一种低成本的普拉格雷的环保制备方法

Similar Documents

Publication Publication Date Title
JP2003246735A5 (https=)
BR0112168A (pt) Composto, sais de adição de ácido de 2-acetoxi-5- (a-ciclopropilcarbonil-2-fluorbenzil) -4,5,6,7-tetrahidrotieno [3,2-c]piridina, medicamento, métodos para prevenção ou tratamento de doenças induzidas pela formação de trombos ou induzidas por embolização em um animal de sangue quente, e para a prevenção ou tratamento de trombose ou embolismo em um humano, e, processos para a preparação de sal de adição de ácido, e de cloridreto de 2-acetoxi-5- (a-ciclopropilcarbonil-2-fluorbenzil) -4,5,6,7-tetrahidrotieno [3,2-c] piridina
WO2005065646A3 (en) Novel drug compositions and dosage forms
CY1108626T1 (el) Ιαματικες συνθεσεις που περιεχουν ασπιρινη
IS7552A (is) Bensótengdar heteróarýl amíð afleiður af þíenópýridíni, gagnlegar sem meðferðarmiðlar, lyfjasamsetningar sem innihalda þær og aðferðir við notkun þeirra
CA2481848A1 (en) Active ingredient particles carrying clopidogrel or a salt thereof, their use and method of preparation
ATE331525T1 (de) Salzformarme polyallylamine
DE69620606D1 (de) Feste oral anzuwendende arzeneiform
NO20040268L (no) Nye 2H-pyridazin-3-derivater, farmasoytiske preparater inneholdende slike og fremgangsmate for fremstilling av den aktive ingrediensen
WO2002088100A3 (de) Deuterierte 3-piperidinopropiophenone sowie diese verbindungen enthaltende arzneimittel
CY1107819T1 (el) Φαρμακευτικη διαμορφωση της ολανζαπινης
HRP20130159T1 (hr) Roskovitin, namijenjen lijeäśenju izvjesnih cistiäśnih bolesti
WO2002102743A3 (de) Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel
CA2489140A1 (en) Dosage form containing pantoprazole as active ingredient
WO2005065648A3 (en) Novel drug compositions and dosage forms of topiramate
JP2002255814A5 (https=)
AU8799001A (en) Pharmaceutically active hydrophilic sulfonamide derivatives as inhibitors of protein junkinases
NO20034985D0 (no) Nye 5-tio-SS-D-xylopyranosid-derivater, fremgangsmåte for fremstilling derav, farmasöytiske blandinger inneholdende dem og den terapeutiskeanvendelse derav
ITMI20001053A0 (it) Derivati 2-amminotetralinici otticamente attivi, procedimenti per la loro preparazione e impiego terapeutico delle corrispondenti composizio
HRP20050497B1 (hr) Uporaba levocetirizina za liječenje stalnog alergijskog rinitisa
NO20031030L (no) Nye krystaller av N-hydroksy-2(S)-metyl-5-etoksymetoksy-4(S)- [N-(4-fenoksyfenylkarbonyl)amino]pentanamid, fremgangsmåte for deresfremstilling og medisinerinneholdende krystallene som den aktive bestanddel
FR2861300B1 (fr) Utilisation d'un derive du pyrazole, pour la preparation de medicaments utiles dans la prevention et le traitement du syndrome metabolique
Vet—QA02BC02 1760 Gastrointestinal Drugs
TH77070A (th) สารผสมทางเภสัชกรรมสำหรับการรักษาอาการโรคของทางเดินปัสสาวะส่วนล่าง
RU2003106097A (ru) Способ управляемого снижения агрегационной активности тромбоцитов в эксперименте